1. Home
  2. CDNA vs LYTS Comparison

CDNA vs LYTS Comparison

Compare CDNA & LYTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CDNA
  • LYTS
  • Stock Information
  • Founded
  • CDNA 1998
  • LYTS 1976
  • Country
  • CDNA United States
  • LYTS United States
  • Employees
  • CDNA N/A
  • LYTS N/A
  • Industry
  • CDNA Medical Specialities
  • LYTS Building Products
  • Sector
  • CDNA Health Care
  • LYTS Consumer Discretionary
  • Exchange
  • CDNA Nasdaq
  • LYTS Nasdaq
  • Market Cap
  • CDNA 712.2M
  • LYTS 700.9M
  • IPO Year
  • CDNA 2014
  • LYTS N/A
  • Fundamental
  • Price
  • CDNA $18.03
  • LYTS $17.96
  • Analyst Decision
  • CDNA Buy
  • LYTS Strong Buy
  • Analyst Count
  • CDNA 7
  • LYTS 2
  • Target Price
  • CDNA $26.00
  • LYTS $27.50
  • AVG Volume (30 Days)
  • CDNA 1.2M
  • LYTS 204.1K
  • Earning Date
  • CDNA 11-04-2025
  • LYTS 11-06-2025
  • Dividend Yield
  • CDNA N/A
  • LYTS 1.12%
  • EPS Growth
  • CDNA N/A
  • LYTS 2.57
  • EPS
  • CDNA 1.22
  • LYTS 0.80
  • Revenue
  • CDNA $357,998,000.00
  • LYTS $592,531,000.00
  • Revenue This Year
  • CDNA $12.73
  • LYTS $5.91
  • Revenue Next Year
  • CDNA $11.90
  • LYTS $8.03
  • P/E Ratio
  • CDNA $14.75
  • LYTS $22.38
  • Revenue Growth
  • CDNA 14.46
  • LYTS 22.35
  • 52 Week Low
  • CDNA $10.96
  • LYTS $13.77
  • 52 Week High
  • CDNA $26.37
  • LYTS $25.50
  • Technical
  • Relative Strength Index (RSI)
  • CDNA 67.03
  • LYTS 30.18
  • Support Level
  • CDNA $15.60
  • LYTS $17.21
  • Resistance Level
  • CDNA $17.09
  • LYTS $18.54
  • Average True Range (ATR)
  • CDNA 1.02
  • LYTS 0.84
  • MACD
  • CDNA 0.15
  • LYTS -0.19
  • Stochastic Oscillator
  • CDNA 95.64
  • LYTS 12.78

About CDNA CareDx Inc.

CareDx Inc operates as a precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. It offers testing services, products, and digital solutions along with the pre- and post-transplant patient journey and is a provider of genomics-based information for transplant patients. The Company's commercially available testing services consist of AlloSure Kidney, AlloMap Heart, AlloSure Heart, a dd-cfDNA solution for heart transplant patients, and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. Geographically the company generates the majority of its revenue from the United States. The company generates the majority of revenue from the Testing services.

About LYTS LSI Industries Inc.

LSI Industries Inc provides corporate visual image solutions to the petroleum and convenience store industry. The company's operating segments include Lighting and Display Solutions. It generates maximum revenue from the Display solutions segment. Lighting Segment manufactures and markets outdoor and indoor lighting and lighting controls for the commercial, industrial, and multi-site retail markets, including the petroleum/convenience store, quick-service, and automotive markets. The Display Solutions Segment manufactures, sells, and installs exterior and interior visual image and display elements, including printed graphics, structural graphics, digital signage, menu board systems, display fixtures, refrigerated displays, and custom display elements.

Share on Social Networks: